US Stock MarketDetailed Quotes

Arbutus Biopharma (ABUS)

Watchlist
  • 4.250
  • -0.180-4.06%
Close Apr 23 16:00 ET
  • 4.391
  • +0.141+3.33%
Post 20:01 ET
836.99MMarket Cap-25.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arbutus Biopharma (ABUS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
128.21%14.08M
-33.23%1.05M
-60.49%529K
522.19%10.74M
15.14%1.76M
-65.98%6.17M
-26.62%1.57M
-71.25%1.34M
-62.89%1.73M
-77.09%1.53M
Operating revenue
128.21%14.08M
-33.23%1.05M
-60.49%529K
522.19%10.74M
15.14%1.76M
-65.98%6.17M
-26.62%1.57M
-71.25%1.34M
-62.89%1.73M
-77.09%1.53M
Cost of revenue
Gross profit
Operating expense
-45.98%41.13M
-35.70%8.7M
-53.10%8.82M
-61.79%8.83M
-28.60%14.79M
-20.83%76.15M
-40.34%13.52M
-27.68%18.81M
-2.42%23.1M
-13.06%20.72M
Selling and administrative expenses
-28.11%15.89M
-21.71%3.69M
-32.91%3.04M
-55.90%3.33M
9.79%5.83M
-1.63%22.11M
-7.63%4.71M
-22.34%4.54M
26.20%7.55M
-4.32%5.31M
-General and administrative expense
-28.11%15.89M
-21.71%3.69M
-32.91%3.04M
-55.90%3.33M
9.79%5.83M
-1.63%22.11M
-7.63%4.71M
-22.34%4.54M
26.20%7.55M
-4.32%5.31M
Research and development costs
-53.29%25.24M
-43.18%5.01M
-59.52%5.78M
-64.65%5.5M
-41.84%8.96M
-26.68%54.04M
-49.84%8.81M
-29.23%14.27M
-12.10%15.55M
-15.72%15.4M
Operating profit
61.34%-27.05M
36.02%-7.64M
52.53%-8.29M
108.95%1.91M
32.09%-13.03M
10.33%-69.97M
41.77%-11.95M
18.18%-17.47M
-12.36%-21.37M
-11.92%-19.18M
Net non-operating interest income expense
-38.42%3.97M
-40.10%859K
-45.93%929K
-43.51%1.01M
-22.12%1.17M
23.31%6.45M
0.91%1.43M
18.65%1.72M
39.15%1.8M
40.28%1.5M
Non-operating interest income
-38.22%4.07M
-40.10%877K
-45.51%952K
-43.03%1.04M
-22.52%1.2M
15.77%6.59M
-0.07%1.46M
16.93%1.75M
25.19%1.83M
21.85%1.55M
Non-operating interest expense
-29.20%97K
-40.00%18K
-20.69%23K
-17.65%28K
-36.36%28K
-70.15%137K
-31.82%30K
-36.96%29K
-80.12%34K
-77.78%44K
Other net income (expense)
-62.98%-10.42M
250.10%3.03M
90.46%-378K
-84.47%-404K
-6,463.73%-12.67M
-14,431.82%-6.39M
-847.42%-2.02M
-1,891.96%-3.96M
-134.38%-219K
28.25%-193K
Gain on sale of security
128.57%14K
103.03%1K
-340.00%-12K
362.50%21K
130.77%4K
-296.00%-49K
-335.71%-33K
-16.67%5K
-900.00%-8K
-425.00%-13K
Special income (charges)
-64.46%-10.44M
252.54%3.03M
90.78%-366K
-101.42%-425K
-6,940.00%-12.67M
-9,095.65%-6.35M
-774.45%-1.99M
-1,836.10%-3.97M
-133.18%-211K
34.07%-180K
-Less：Restructuring and merger&acquisition
75.08%11.11M
-218.59%-2.35M
-90.78%366K
101.42%425K
6,940.00%12.67M
9,095.65%6.35M
774.45%1.99M
1,836.10%3.97M
133.18%211K
-34.07%180K
-Gain on sale of property,plant,equipment
--674K
----
----
----
----
--0
----
----
----
----
Income before tax
52.09%-33.5M
70.03%-3.76M
60.73%-7.74M
112.74%2.52M
-37.21%-24.53M
4.02%-69.92M
35.11%-12.53M
1.92%-19.72M
-15.81%-19.8M
-9.40%-17.88M
Income tax
0
Net income
52.09%-33.5M
70.03%-3.76M
60.73%-7.74M
112.74%2.52M
-37.21%-24.53M
4.02%-69.92M
35.11%-12.53M
1.92%-19.72M
-15.81%-19.8M
-9.40%-17.88M
Net income continuous Operations
52.09%-33.5M
70.03%-3.76M
60.73%-7.74M
112.74%2.52M
-37.21%-24.53M
4.02%-69.92M
35.11%-12.53M
1.92%-19.72M
-15.81%-19.8M
-9.40%-17.88M
Minority interest income
Net income attributable to the parent company
52.09%-33.5M
70.03%-3.76M
60.73%-7.74M
112.74%2.52M
-37.21%-24.53M
4.02%-69.92M
35.11%-12.53M
1.92%-19.72M
-15.81%-19.8M
-9.40%-17.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
52.09%-33.5M
70.03%-3.76M
60.73%-7.74M
112.74%2.52M
-37.21%-24.53M
4.02%-69.92M
35.11%-12.53M
1.92%-19.72M
-15.81%-19.8M
-9.40%-17.88M
Basic earnings per share
55.26%-0.17
85.71%-0.01
60.00%-0.04
109.09%0.01
-30.00%-0.13
13.64%-0.38
41.67%-0.07
16.67%-0.1
-10.00%-0.11
0.00%-0.1
Diluted earnings per share
55.26%-0.17
85.71%-0.01
60.00%-0.04
109.09%0.01
-30.00%-0.13
13.64%-0.38
41.67%-0.07
16.67%-0.1
-10.00%-0.11
0.00%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 128.21%14.08M-33.23%1.05M-60.49%529K522.19%10.74M15.14%1.76M-65.98%6.17M-26.62%1.57M-71.25%1.34M-62.89%1.73M-77.09%1.53M
Operating revenue 128.21%14.08M-33.23%1.05M-60.49%529K522.19%10.74M15.14%1.76M-65.98%6.17M-26.62%1.57M-71.25%1.34M-62.89%1.73M-77.09%1.53M
Cost of revenue
Gross profit
Operating expense -45.98%41.13M-35.70%8.7M-53.10%8.82M-61.79%8.83M-28.60%14.79M-20.83%76.15M-40.34%13.52M-27.68%18.81M-2.42%23.1M-13.06%20.72M
Selling and administrative expenses -28.11%15.89M-21.71%3.69M-32.91%3.04M-55.90%3.33M9.79%5.83M-1.63%22.11M-7.63%4.71M-22.34%4.54M26.20%7.55M-4.32%5.31M
-General and administrative expense -28.11%15.89M-21.71%3.69M-32.91%3.04M-55.90%3.33M9.79%5.83M-1.63%22.11M-7.63%4.71M-22.34%4.54M26.20%7.55M-4.32%5.31M
Research and development costs -53.29%25.24M-43.18%5.01M-59.52%5.78M-64.65%5.5M-41.84%8.96M-26.68%54.04M-49.84%8.81M-29.23%14.27M-12.10%15.55M-15.72%15.4M
Operating profit 61.34%-27.05M36.02%-7.64M52.53%-8.29M108.95%1.91M32.09%-13.03M10.33%-69.97M41.77%-11.95M18.18%-17.47M-12.36%-21.37M-11.92%-19.18M
Net non-operating interest income expense -38.42%3.97M-40.10%859K-45.93%929K-43.51%1.01M-22.12%1.17M23.31%6.45M0.91%1.43M18.65%1.72M39.15%1.8M40.28%1.5M
Non-operating interest income -38.22%4.07M-40.10%877K-45.51%952K-43.03%1.04M-22.52%1.2M15.77%6.59M-0.07%1.46M16.93%1.75M25.19%1.83M21.85%1.55M
Non-operating interest expense -29.20%97K-40.00%18K-20.69%23K-17.65%28K-36.36%28K-70.15%137K-31.82%30K-36.96%29K-80.12%34K-77.78%44K
Other net income (expense) -62.98%-10.42M250.10%3.03M90.46%-378K-84.47%-404K-6,463.73%-12.67M-14,431.82%-6.39M-847.42%-2.02M-1,891.96%-3.96M-134.38%-219K28.25%-193K
Gain on sale of security 128.57%14K103.03%1K-340.00%-12K362.50%21K130.77%4K-296.00%-49K-335.71%-33K-16.67%5K-900.00%-8K-425.00%-13K
Special income (charges) -64.46%-10.44M252.54%3.03M90.78%-366K-101.42%-425K-6,940.00%-12.67M-9,095.65%-6.35M-774.45%-1.99M-1,836.10%-3.97M-133.18%-211K34.07%-180K
-Less：Restructuring and merger&acquisition 75.08%11.11M-218.59%-2.35M-90.78%366K101.42%425K6,940.00%12.67M9,095.65%6.35M774.45%1.99M1,836.10%3.97M133.18%211K-34.07%180K
-Gain on sale of property,plant,equipment --674K------------------0----------------
Income before tax 52.09%-33.5M70.03%-3.76M60.73%-7.74M112.74%2.52M-37.21%-24.53M4.02%-69.92M35.11%-12.53M1.92%-19.72M-15.81%-19.8M-9.40%-17.88M
Income tax 0
Net income 52.09%-33.5M70.03%-3.76M60.73%-7.74M112.74%2.52M-37.21%-24.53M4.02%-69.92M35.11%-12.53M1.92%-19.72M-15.81%-19.8M-9.40%-17.88M
Net income continuous Operations 52.09%-33.5M70.03%-3.76M60.73%-7.74M112.74%2.52M-37.21%-24.53M4.02%-69.92M35.11%-12.53M1.92%-19.72M-15.81%-19.8M-9.40%-17.88M
Minority interest income
Net income attributable to the parent company 52.09%-33.5M70.03%-3.76M60.73%-7.74M112.74%2.52M-37.21%-24.53M4.02%-69.92M35.11%-12.53M1.92%-19.72M-15.81%-19.8M-9.40%-17.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 52.09%-33.5M70.03%-3.76M60.73%-7.74M112.74%2.52M-37.21%-24.53M4.02%-69.92M35.11%-12.53M1.92%-19.72M-15.81%-19.8M-9.40%-17.88M
Basic earnings per share 55.26%-0.1785.71%-0.0160.00%-0.04109.09%0.01-30.00%-0.1313.64%-0.3841.67%-0.0716.67%-0.1-10.00%-0.110.00%-0.1
Diluted earnings per share 55.26%-0.1785.71%-0.0160.00%-0.04109.09%0.01-30.00%-0.1313.64%-0.3841.67%-0.0716.67%-0.1-10.00%-0.110.00%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +18.81%
Sample Name
Sample Code
 +16.13%
Sample Name
Sample Code
 +12.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+11.25%
5
United Sts Brent Oil Fd Lp Unit
BNO
+8.06%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +13.80%
Sample Name
Sample Code
 +12.99%
Sample Name
Sample Code
 +8.01%
4
Chagee Holdings
CHA
+5.92%
5
Taiwan Semiconductor
TSM
+5.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
At midnight Beijing time on April 24, Iranian Parliament Speaker Kalibaf announced his withdrawal from the Iran-US negotiation delegation. M Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -